Similarly, mutant KRAS-G12V is sufficient to induce pancreatic ductal adenocarcinoma in mice, when expressed in embryonic cells of acinar lineage, whereas chronic inflammation in combination with KRAS-G12V expression is required for pancreatic tumorigenesis in adult mice [25]. Here, KRAS is linked to pancreatic ductal adenocarcinoma.